Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Bo Littbrand"'
Autor:
Matti Mäntylä, Inkeri Elomaa, Johanna Mattson, Pia Lindroos, Dick Killander, Bo Littbrand, Jens Overgaard, Mikko Tenhunen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/5a6e7ed428e4445e8d5cc01a172585ec
Autor:
Björn Zackrisson, Elisabeth Kjellén, Bengt Glimelius, Jörgen Carlsson, Bo Littbrand, Ingela Turesson, The Swedish Cancer Society Investigatio
Publikováno v:
Acta oncologica (Stockholm, Sweden). 41(7-8)
In an investigation by the Swedish Cancer Society, an expert group described the present status, critical issues and future aspects and potentials for each of nine major areas of radiation therapy research. The present report deals with the use of se
Autor:
Eva Cavallin-Ståhl, Jeanette Ceberg, Torgil R. Möller, Bo Littbrand, Jan-erik Frödin, Christer Lindholm
Publikováno v:
Acta Oncologica. 42:416-429
A systematic assessment of radiotherapy for cancer was conducted by The Swedish Council on Technology Assessment in Health Care (SBU) in 2001. The assessment included a critical review of the literature on radiotherapy for cancer published in 1994-20
Autor:
Eva Forssell-Aronsson, Sören Mattsson, Bengt Glimelius, Juliana Denekamp, Anders Brahme, Elisabeth Kjellén, Ingela Turesson, Bo Stenerlöw, Karl-Axel Johansson, Jörgen Carlsson, Bo Littbrand, Mikael Hellström, Björn Zackrisson, Bo Nordenskjöld
Publikováno v:
Acta Oncologica. 41:596-603
In an investigation by the Swedish Cancer Society, the present status, critical issues and future aspects and prospects were described by an expert group for each of nine major areas of radiation research. A summary of the investigation is presented
Publikováno v:
Acta Oncologica. 36:499-507
Conventional 4-field box radiotherapy technique induces high morbidity for patients with localized prostatic cancer. Using a patient daily diary, the present study compared side-effects after conventional radiotherapy with conformal radiotherapy for
Publikováno v:
Acta Oncologica. 34:219-223
Radiotherapy of head and neck malignancies is accompanied by oral discomforts, such as epithelitis, pain and functional impairment. This can lead to chronic sequalae with subjective distress such as loss of taste and xerostomia and pronounced decreas
Autor:
Bo Littbrand, Juliana Denekamp, Björn Zackrisson, Madeleine F. Dennis, Ana M. Rojas, Michael R.L. Stratford, Lars Franzén, Roger Henriksson
Publikováno v:
Europe PubMed Central
Combining accelerated radiotherapy with carbogen and nicotinamide (NAM) has been proposed as a strategy to overcome the sparing effect of tumour clonogen repopulation and hypoxia. Six patients with squamous cell carcinomas of the head and neck were g
Publikováno v:
Acta Oncologica. 33:397-402
One hundred and sixty-eight patients with invasive bladder cancer, T2-T4, were randomized to one of two treatments; hyperfractionation with 1 Gy 3 times a day to a total of 84 Gy or conventional treatment 2 Gy once a day to a total of 64 Gy. Both tre
Publikováno v:
Scandinavian Journal of Gastroenterology. 27:7-11
In a double-blind randomized placebo-controlled study, including 70 patients treated with radiotherapy of localized malignancies in the pelvis, the effects of prophylactic sucralfate in preventing bowel discomfort were evaluated. Radiotherapy was del
Autor:
Roger Henriksson, Lars Franzén, Staffan Sundström, Mikael Karlsson, Hans Gustafsson, Bo Littbrand
Publikováno v:
Acta Oncologica. 31:359-364
The effects of fractionated irradiation on the electrolyte fluid secretion from rat parotid gland were studied. Secretion was measured as noradrenaline stimulated potassium efflux in vitro with 86Rb+ as tracer for potassium. The irradiation was deliv